Javier Ortego

Valdeolmos, MD 28130, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

The Changing Landscape of Akabane Virus: A Comprehensive Review.

The Changing Landscape of Akabane Virus: A Comprehensive Review.

Journal: Viruses
Published: June 10, 2026

Cryo-EM structure of African horse sickness virus VP2 receptor-binding protein enables nanoparticle vaccine design.

Cryo-EM structure of African horse sickness virus VP2 receptor-binding protein enables nanoparticle vaccine design.

Journal: Nature communications
Published: January 09, 2026

Multivalent Disabled Infectious Single Animal (DISA)-DIVA vaccine for all nine serotypes of African horse sickness virus (AHSV) is broadly protective in IFNAR (-/-) mice.

Multivalent Disabled Infectious Single Animal (DISA)-DIVA vaccine for all nine serotypes of African horse sickness virus (AHSV) is broadly protective in IFNAR (-/-) mice.

Journal: Veterinary research
Published: December 12, 2025

Structure-Guided Engineering of Protein VP2 from Epizootic Hemorrhagic Disease Virus Maximizes Production and Confers Complete Protection as Subunit Vaccine.

Structure-Guided Engineering of Protein VP2 from Epizootic Hemorrhagic Disease Virus Maximizes Production and Confers Complete Protection as Subunit Vaccine.

Journal: Vaccines
Published: November 11, 2025

Rapid Quantification of Bluetongue Virus-Neutralizing Antibodies Using Bioluminescent Reporter-Expressing Viruses.

Rapid Quantification of Bluetongue Virus-Neutralizing Antibodies Using Bioluminescent Reporter-Expressing Viruses.

Journal: Vaccines
Published: October 03, 2025

Generation and characterization of an ovine cell line derived from peripheral blood and its potential use in the study of livestock and zoonotic viral infections.

Generation and characterization of an ovine cell line derived from peripheral blood and its potential use in the study of livestock and zoonotic viral infections.

Journal: Virology journal
Published: June 20, 2025

The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus.

The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus.

Journal: Frontiers in immunology
Published: January 24, 2025

Vaccine candidates based on MVA viral vectors expressing VP2 or VP7 confer full protection against Epizootic hemorrhagic disease virus in IFNAR(-/-) mice.

Vaccine candidates based on MVA viral vectors expressing VP2 or VP7 confer full protection against Epizootic hemorrhagic disease virus in IFNAR(-/-) mice.

Journal: Journal of virology
Published: November 07, 2024

Locating Insulation Defects in HV Substations Using HFCT Sensors and AI Diagnostic Tools.

Locating Insulation Defects in HV Substations Using HFCT Sensors and AI Diagnostic Tools.

Journal: Sensors (Basel, Switzerland)
Published: June 19, 2024

Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus.

Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus.

Journal: Frontiers in immunology
Published: May 29, 2024

Novel Reference Method for the Characterization of PD Measuring Systems Using HFCT Sensors.

Novel Reference Method for the Characterization of PD Measuring Systems Using HFCT Sensors.

Journal: Sensors (Basel, Switzerland)
Published: April 08, 2024

Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for in vitro and non-invasive in vivo studies.

Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for in vitro and non-invasive in vivo studies.

Journal: Microbiology spectrum
Published: February 14, 2024
Showing 1-12 of 50

Last Updated: 09/26/2026